Stanford Medicine X-Health Care and Emerging Technologies
斯坦福大学医学 X-医疗保健和新兴技术
基本信息
- 批准号:8431532
- 负责人:
- 金额:$ 9.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-01 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Stanford Medicine X is a conference dedicated to innovation and the application of emerging technology to improve medicine and health care. One central aspect of innovation at the core of the mission of our conference is to re-engineer the entire system of research and care of patients with chronic disease. Where our current system might represent an upside-down pyramid where knowledge and innovation is expected to spring up from the top of a rigid hierarchy, with highly specialized academics and practitioners
at the top, and eventually trickle down to patients, our hypothesis is that it makes sense for knowledge to derive from the real experts: patients and their caregivers. Therefore, we believe that there can be a new approach to an academic conference that places the patient at the center of discussion and that will unite all healthcare stakeholders- patients, healthcare professionals, technologists, and researchers-together to help solve health care issues from a patient centered perspective. There is no other academic conference dedicated to exploring the intersection of healthcare and emerging technologies specifically from a patient-centered perspective. This proposal seeks funding through the AHRQ R13 grant mechanism to support the conference meetings in 2012, 2013, and 2014. The sole PI for the conference outlined in this proposal is Larry Chu, MD, MS, head of the Anesthesia Informatics and Media (AIM) Lab at Stanford, Associate Professor of Anesthesia, and Organizing Chair for the successful Medicine 2.0 Summit and 4th World Congress at Stanford. Stanford Medicine X will convene for three days annually in September at the Li Ka Shing Center for Learning on the Stanford campus. The objectives of the Medicine X are: 1. To advance understanding of how innovative technologies have the potential to improve patient care and ease the burden of disease from a patient-centered perspective, including tools to empower patients to be involved in their own care. 2. To provide a forum concentrated on uniting stakeholders in health care for opportunities to network and collaborate in innovative, interdisciplinary research and/or technology solutions. 3. To provide education in major areas relevant to emerging technology and their application to clinical medicine. 4. To integrate the patient voice and patient-centered design into the use of emerging technologies to improve health care. 5. To identify those measureable outcomes that are most meaningful to patients and to bring researchers closer to understanding how to incorporate patient-centered design and outcomes into their research. The meeting will be one of the major venues for researchers in the realm of emerging technology and medicine to present and publish their work and to network with a diverse audience of health care providers, patients, technologists, and academicians. Conference proceedings will be published in the official open access conference journals: Journal of Visualized Experiments (JoVE) and Public Library of Science (PLoS ONE). The location of Medicine X at the Stanford School of Medicine allows attendees the access to a breadth of experts and an unmatched number of technologists and health start-ups based in the Silicon Valley.
PUBLIC HEALTH RELEVANCE: The Stanford Medicine X conference will be a forum for discussion of emerging technologies and their impact on the future of medicine and health care, from a patient-centered perspective. There is no other meeting dedicated to exploring the intersection of healthcare and emerging technologies specifically from a patient- centered perspective. Medicine X is focused on bringing health care stakeholders together in an academic conference that shares a stage between researchers, leaders in innovation, and patients.
描述(由申请者提供):斯坦福医学X是一个致力于创新和应用新兴技术来改善医学和医疗保健的会议。创新的一个核心方面是重新设计整个慢性病患者研究和护理系统,这是本次会议使命的核心。我们目前的体系可能代表着一个颠倒的金字塔,在那里,知识和创新有望从僵化的等级制度的顶端涌现出来,拥有高度专业化的学者和实践者
我们的假设是,从真正的专家--患者及其照顾者--那里获得知识是有意义的。从最高层,并最终向下渗透到患者身上。因此,我们相信,学术会议可以有一种新的方法,将患者放在讨论的中心,并将所有医疗保健利益相关者-患者、医疗保健专业人员、技术专家和研究人员-团结在一起,从患者中心的角度帮助解决医疗保健问题。没有其他学术会议专门从以患者为中心的角度来探索医疗保健和新兴技术的交叉。该提案寻求通过AHRQ R13赠款机制提供资金,以支持2012年、2013年和2014年的会议。这项提案中概述的会议的唯一PI是Larry Chu,医学博士,硕士,斯坦福大学麻醉信息学和媒体(AIM)实验室负责人,麻醉学副教授,斯坦福成功医学2.0峰会和第四次世界大会的组织主席。斯坦福医学X将于每年9月在斯坦福校园的李嘉诚学习中心举行为期三天的会议。Medicine X的目标是:1.从以患者为中心的角度加深对创新技术如何具有改善患者护理和减轻疾病负担的潜力的理解,包括使患者能够参与自己护理的工具。2.提供一个论坛,集中于联合保健领域的利益攸关方,争取机会在创新、跨学科的研究和/或技术解决方案方面建立网络并进行合作。3.提供与新兴技术及其在临床医学中的应用相关的主要领域的教育。4.将患者呼声和以患者为中心的设计融入新兴技术的使用中,以改善医疗保健。5.确定对患者最有意义的可测量结果,并使研究人员更接近于了解如何将以患者为中心的设计和结果纳入他们的研究。会议将是新兴技术和医学领域的研究人员展示和发表他们的工作并与医疗保健提供者、患者、技术人员和院士的不同受众建立网络的主要场所之一。会议记录将发表在官方开放获取会议期刊上:《可视化实验杂志》(JoVE)和《公共科学图书馆》(PLoS One)。X医学中心位于斯坦福医学院,让与会者可以接触到众多专家,以及数量无与伦比的硅谷技术专家和医疗初创企业。
与公共健康相关:斯坦福医学X大会将是一个论坛,从以患者为中心的角度讨论新兴技术及其对未来医学和医疗保健的影响。没有其他会议专门从以患者为中心的角度探索医疗保健和新兴技术的交叉。MedicX专注于将医疗保健利益相关者聚集在一个学术会议上,该会议在研究人员、创新领导者和患者之间共享一个舞台。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LAWRENCE F CHU其他文献
LAWRENCE F CHU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LAWRENCE F CHU', 18)}}的其他基金
Understanding the Effects of Chronic Opioids Therapy in Humans
了解慢性阿片类药物治疗对人类的影响
- 批准号:
8636421 - 财政年份:2013
- 资助金额:
$ 9.87万 - 项目类别:
Understanding the Effects of Chronic Opioids Therapy in Humans
了解慢性阿片类药物治疗对人类的影响
- 批准号:
8509170 - 财政年份:2013
- 资助金额:
$ 9.87万 - 项目类别:
Stanford Medicine X-Health Care and Emerging Technologies
斯坦福大学医学 X-医疗保健和新兴技术
- 批准号:
8530189 - 财政年份:2012
- 资助金额:
$ 9.87万 - 项目类别:
Stanford Medicine X-Health Care and Emerging Technologies
斯坦福大学医学 X-医疗保健和新兴技术
- 批准号:
8691496 - 财政年份:2012
- 资助金额:
$ 9.87万 - 项目类别:
5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Phy
5HT3 拮抗剂治疗阿片类药物戒断并预防 Physical 进展
- 批准号:
8240984 - 财政年份:2011
- 资助金额:
$ 9.87万 - 项目类别:
5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Phy
5HT3 拮抗剂治疗阿片类药物戒断并预防 Physical 进展
- 批准号:
8451522 - 财政年份:2011
- 资助金额:
$ 9.87万 - 项目类别:
5HT3 Antagonists to Treat Opioid Withdrawal and to Prevent the Progression of Phy
5HT3 拮抗剂治疗阿片类药物戒断并预防 Physical 进展
- 批准号:
8041122 - 财政年份:2011
- 资助金额:
$ 9.87万 - 项目类别:
Opiate-Induced Tolerance & Hyperalgesia in Pain Patients
阿片类药物引起的耐受性
- 批准号:
7118009 - 财政年份:2004
- 资助金额:
$ 9.87万 - 项目类别:
Opiate-Induced Tolerance & Hyperalgesia in Pain Patients
阿片类药物引起的耐受性
- 批准号:
6807970 - 财政年份:2004
- 资助金额:
$ 9.87万 - 项目类别:
Opiate-Induced Tolerance & Hyperalgesia in Pain Patients
阿片类药物引起的耐受性
- 批准号:
6918649 - 财政年份:2004
- 资助金额:
$ 9.87万 - 项目类别:
相似国自然基金
Chinese Journal of Integrative Medicine
- 批准号:81224004
- 批准年份:2012
- 资助金额:24.0 万元
- 项目类别:专项基金项目
相似海外基金
SBIR Phase II: Zero Trust Solution for Precision Medicine and Precision Health Data Exchanges
SBIR 第二阶段:精准医疗和精准健康数据交换的零信任解决方案
- 批准号:
2226026 - 财政年份:2024
- 资助金额:
$ 9.87万 - 项目类别:
Cooperative Agreement
Medicine Bundle for Two-Spirit and Indigiqueer Peoples: Expanding and Adapting an Indigenous-Led Sexual Health Testing Program from Colonial British Columbia Across Turtle Island
为两种精神和土著民族提供的药物组合:在海龟岛上扩展和调整不列颠哥伦比亚殖民地的土著主导的性健康测试计划
- 批准号:
487633 - 财政年份:2023
- 资助金额:
$ 9.87万 - 项目类别:
Operating Grants
The Arts as Medicine? New Histories of the Arts and Health
艺术作为医学?
- 批准号:
AH/X008797/1 - 财政年份:2023
- 资助金额:
$ 9.87万 - 项目类别:
Research Grant
Linking Social-Behavior Contextual Factors and Allostatic Load to Chronic Diseases in Diverse Asian Americans: A Socioecological Approach to Advancing Precision Medicine and Health Equity
将社会行为背景因素和稳态负荷与不同亚裔美国人的慢性病联系起来:推进精准医疗和健康公平的社会生态学方法
- 批准号:
10799170 - 财政年份:2023
- 资助金额:
$ 9.87万 - 项目类别:
Race, War, and Medicine: The Transdisciplinary Bridge between Asian American Literary Studies and Health/Medical Humanities
种族、战争与医学:亚裔美国文学研究与健康/医学人文学科之间的跨学科桥梁
- 批准号:
23K00403 - 财政年份:2023
- 资助金额:
$ 9.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Evaluating and facilitating the implementation of stepped and measurement-based mental health care in Family Medicine Groups
评估和促进家庭医学小组中阶梯式和基于测量的心理保健的实施
- 批准号:
490034 - 财政年份:2023
- 资助金额:
$ 9.87万 - 项目类别:
Operating Grants
Institute for Integration of Medicine & Science: A Partnership to Improve Health
医学整合研究所
- 批准号:
10704865 - 财政年份:2023
- 资助金额:
$ 9.87万 - 项目类别:
We Are All Scientists - promotes precision medicine and health research in Indigenous communities through a large scale multimedia campaign and building of strategic partnerships with schools and TCUs
我们都是科学家 - 通过大规模多媒体活动以及与学校和 TCU 建立战略合作伙伴关系,促进原住民社区的精准医学和健康研究
- 批准号:
10912329 - 财政年份:2023
- 资助金额:
$ 9.87万 - 项目类别:
23 and bee: Molecular medicine for early and effective diagnostics and monitoring of honeybee health
23 和蜜蜂:用于早期有效诊断和监测蜜蜂健康的分子医学
- 批准号:
2879918 - 财政年份:2023
- 资助金额:
$ 9.87万 - 项目类别:
Studentship
Leveraging precision medicine and eHealth to predict cancer predisposition syndromes in children: A Canadian initiative to redress global health disparities in cancer genetics
利用精准医学和电子健康来预测儿童癌症易感综合症:加拿大旨在纠正癌症遗传学方面全球健康差异的一项举措
- 批准号:
479489 - 财政年份:2023
- 资助金额:
$ 9.87万 - 项目类别:
Operating Grants














{{item.name}}会员




